Bal Pharma Limited

NSE:BALPHARMA.NS

127.24 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q2
Revenue 743.587946.26816.635925.427701.659824.508766.188753.073698.393740.494691.667671.716708.258708.105630.28645.606521.294337.723431.723449.872491.625550.731535.674574.828535.674589.068520.429643.469586.472662.507446.185548.124463.527558.578412.937520.646429.427498.097423.403490.722442.513478.465377.021428.188353.612397.455299.89403.093363.869346.594
Cost of Revenue 564.132715.575458.475533.145387.902450.992448.817419.314408.576478.27401.025358.487458.792433.116369.811413.093296.232164.864225.554209.45256.178283.429299.391273.468299.391270.313250.99308.308292.855350.555210.533307.618216.784313.83209.577276.401224.668273.139217.83268.63235.122269.129179.437234.094180.478229.057145.82214.521211.717190.653
Gross Profit 179.455230.685358.16392.282313.757373.516317.371333.759289.817262.224290.642313.229249.466274.989260.469232.513225.062172.859206.169240.422235.447267.302236.283301.36236.283318.755269.439335.161293.617311.952235.652240.506246.743244.748203.36244.246204.759224.958205.573222.091207.391209.336197.584194.094173.134168.398154.07188.573152.152155.941
Gross Profit Ratio 0.2410.2440.4390.4240.4470.4530.4140.4430.4150.3540.420.4660.3520.3880.4130.360.4320.5120.4780.5340.4790.4850.4410.5240.4410.5410.5180.5210.5010.4710.5280.4390.5320.4380.4920.4690.4770.4520.4860.4530.4690.4380.5240.4530.490.4240.5140.4680.4180.45
Reseach & Development Expenses 0000049.19400032.03900031.74600033.77500028.93100016.446019.12600041.07400032.7100028.07600028.61000000
General & Administrative Expenses 00000000000000000000000000000000000000028.8700020.838000000
Selling & Marketing Expenses 000000000000000000000000000000000000000120.23500091.892000000
SG&A 139.08156.317127.649162.321109.34145.571115.262133.362116.056119.914106.166130.73172.767105.052110.684103.86994.974116.25123.361135.122133.697136.47131.323131.822119.496146.788114.523132.772116.125118.49103.114117.74891.61397.29380.55799.96978.7281.01176.433305.65671.41569.80565.53245.102000000
Other Expenses 8.18424.5410.9531.4214.4751.8824.6030.482.4412.8557.5245.5951.3753.6161.9140.6361.5622.6344.1120.2512.301-17.5267.6110.5637.611-2.3630317.724270.569269.972209.656242.308209.076206.648186.053231.720.1024.3040.603188.1850.4611.4910.79-2.7810.661.2781.036-3.571.1121.415
Operating Expenses 139.08156.317309.844339.498266.562312.75280.335299.698261.735249.403250.592271.375196.524224.382221.485183.244193.046199.363213.318235.613232.719226.016212.041271.622212.041281.015237.125317.724270.569269.972209.656242.308209.076206.648186.053231.72178.62188.615176.742188.185173.027175.266168.552154.668140.317136.823133.719147.91129.682130.912
Operating Income 40.37574.36849.26954.20451.6762.64741.63934.54228.08210.25340.0541.85452.94250.60738.98449.26932.016-26.504-7.1494.8092.72841.28624.24229.73824.24237.7431.53817.43723.04841.9825.996-1.80237.66738.117.30712.52626.13936.34328.83133.90734.36434.0729.03239.42632.81731.57520.35140.66322.4725.029
Operating Income Ratio 0.0540.0790.060.0590.0740.0760.0540.0460.040.0140.0580.0620.0750.0710.0620.0760.061-0.078-0.0170.0110.0060.0750.0450.0520.0450.0640.0610.0270.0390.0630.058-0.0030.0810.0680.0420.0240.0610.0730.0680.0690.0780.0710.0770.0920.0930.0790.0680.1010.0620.072
Total Other Income Expenses Net -34.2-16.854-36.608-38.212-36.359-38.531-31.098-28.551-21.24412.524-16.048-21.408-28.342-45.324-26.996-31.224-26.306-21.536-23.962-33.065-30.614-46.745-18.975-30.759-18.975-29.062-22.403-23.276-20.267-21.948-19.362-20.926-17.102-13.745-13.003-10.73-15.721-14.313-15.67-14.465-17.275-15.964-17.41-16.539-18.536-20.405-17.798-11.918-17.903-16.126
Income Before Tax 6.17557.51412.66115.99215.31124.11610.5415.9916.83822.77724.00220.44624.65.28311.98818.0455.71-48.04-31.111-28.256-27.886-5.4595.267-1.0215.2678.6789.135-5.8392.78120.0326.634-22.72820.56524.3554.3041.79610.41822.0313.16119.44217.08918.10611.62222.88714.28111.172.55328.7444.5678.903
Income Before Tax Ratio 0.0080.0610.0160.0170.0220.0290.0140.0080.010.0310.0350.030.0350.0070.0190.0280.011-0.142-0.072-0.063-0.057-0.010.01-0.0020.010.0150.018-0.0090.0050.030.015-0.0410.0440.0440.010.0030.0240.0440.0310.040.0390.0380.0310.0530.040.0280.0090.0710.0130.026
Income Tax Expense 3.5812.1894.1696.2993.3597.9424.6254.7333.9920.90219.2596.5068.109-30.0257.97713.0462.907-0.6795.956-8.359-3.294-18.549-10.5736.525-10.57312.1034.41812.4235.29711.321.946.9689.0226.1251.7860.9262.5765.0523.325.8633.1854.0112.4781.6683.8661.890.6322.48212.5
Net Income 2.59154.7338.8899.45711.95216.0045.7491.1412.84519.7076.39513.79216.49235.7833.174.2444.226-40.626-37.067-19.897-24.59129.4415.84-7.54615.84-3.4254.717-8.7786.07817.5025.056-26.16618.90520.4772.711.6187.84216.9789.84113.57913.90414.0969.14521.21910.4159.281.92116.74713.0826.403
Net Income Ratio 0.0030.0580.0110.010.0170.0190.0080.0020.0040.0270.0090.0210.0230.0510.0050.0070.008-0.12-0.086-0.044-0.050.0530.03-0.0130.03-0.0060.009-0.0140.010.0260.011-0.0480.0410.0370.0070.0030.0180.0340.0230.0280.0310.0290.0240.050.0290.0230.0060.0420.0360.018
EPS 0.163.730.560.60.761.020.390.0730.191.50.320.971.072.480.280.30.3-2.87-2.62-1.4-1.732.081.12-0.531.12-0.240.33-0.620.430.120.04-2.031.521.520.210.170.811.320.781.281.321.330.862.020.990.880.181.591.240.61
EPS Diluted 0.163.730.560.60.761.020.390.070.191.50.320.971.072.480.280.30.3-2.87-2.62-1.4-1.732.081.12-0.531.12-0.240.33-0.620.430.120.04-2.031.521.520.210.170.811.320.781.281.321.330.862.020.990.880.181.591.240.61
EBITDA 64.65995.91978.89578.39672.89483.51366.11858.22452.77952.52569.7169.43976.23356.94861.21871.63452.3760.9411.13418.57918.22435.80846.26541.9246.26555.12442.93839.93936.3156.11741.00120.73453.89253.39433.34342.95537.72447.8140.04544.07845.42745.00644.25857.7943.0341.55329.91646.92331.39934.107
EBITDA Ratio 0.0870.1010.0970.0850.1040.1010.0860.0770.0760.0710.1010.1030.1080.080.0970.1110.10.0030.0260.0410.0370.0650.0860.0730.0860.0940.0830.0620.0620.0850.0920.0380.1160.0960.0810.0830.0880.0960.0950.090.1030.0940.1170.1350.1220.1050.10.1160.0860.098